Scottsdale, AZ – June 10, 2019 – Systems Oncology (SO) announced today it has moved to the Biomedical Collaborative Research Building, an expanded officespace in Scottsdale, Arizona. The new location at the intersection of Scottsdale Road and Loop 101offers SO more office space as well as potential lab and manufacturing space to support the company’s growth in the coming years. The new site is a great addition to its existing locations in Chicago, Toronto, and San Francisco.
The building offers over 368,000 square feet of space and provides SO with a state-of-the-art facility with numerous amenities including a 110-person auditorium, workout facility, three-level parking garage, rooftop garden, and over an acre of outdoor space boasting a view of the McDowell Mountains and Sonoran Desert. The central atrium is topped by an energy-efficient skylight, which is the first of its kind in the Western United States. The building was designed in order to feed natural light into over 75% of the employee work spaces while also reducing the intensity of the sunlight. It is a prime location with easy access to highways and major shopping centers, as well as renowned research institutes, universities and hospitals in the greater Phoenix area.
The Biomedical Collaborative Research Building provides the opportunity for a unique scientific hub that will attract scientists, clinicians, and business partners to network and collaborate in one place. This new facility will encourage entrepreneurial thinking and innovation to face challenges in the healthcare industry.
“This is an exciting time for us as we continue to grow and expand our pipeline,” said Dr. Spyro Mousses, CEO of Systems Oncology. “Relocating our headquarters creates an excellent new opportunity for us to expand our talent, technology, and capabilities. The collaborative environment will also foster meaningful scientific alliances and networking opportunities that lead to innovative thinking. This new world-class facility will allow us to grow for years to come and fulfill our commitment to bring forward breakthrough oncology therapeutics for unmet patient needs.”
About Systems Oncology
Systems Oncology (SO) combines multi-scalar systems modeling with machine learning and big-data to uncover breakthrough insights into cancer biology and expose new therapeutic vulnerabilities. These discoveries are then used to better develop truly novel therapeutic agents. SO has the experience and knowhow needed to intelligently translate scientific insights into smarter clinical development strategies and faster registration paths. It then partners with leading pharmaceutical companies to accelerate the development of breakthrough cancer treatments. Fundamental to the SO approach is a next-generation AI platform for translating scientific insights into innovative cancer therapies with unprecedented speed, scale, and precision.